Document is current
Any future updates will be listed below
-
Authors
Wyss, Anja
Jordan, Suzana
Graf, Nicole
Carreira, Patricia E.
Distler, Jörg
Cerinic, Marco Matucci
Siegert, Elise
Henes, Jörg
Zanatta, Elisabetta
Riccieri, Valeria
Truchetet, Marie-Elise
Oksel, Fahrettin
Li, Mengtao
Kucharz, Eugene J.
Eyerich, Kilian
Del Galdo, Francesco
Vonk, Madelon C.
Vold, Anna-Maria Hoffman
Gabrielli, Armando
Distler, Oliver
,
Walker, Ulrich
Iannone, Florenzo
Becvar, Radim
Cuomo, Giovana
Rednic, Simona
Allanore, Yannick
Montecucco, C.
Novak, Srdan
Czirják, László
Iudici, Michele
Pirkmajer, Katja Perdan
Coleiro, Bernard
Farge Bancel, Dominique
Airò, Paolo
Hesselstrand, Roger
Radic, Mislav
Balbir-Gurman, Alexandra
Hunzelmann, Nicolas
Pellerito, Raffaele
Giollo, Alessandro
Denton, Christopher
Damjanov, Nemanja
Ortiz-Santamaria, Vera
Heitmann, Stefan
Seidel, Matthias
Salvador, Maria João
Stamenkovic, Bojana
Selmi, Carlo Francesco
Tikly, Mohammed
Ananieva, Lidia P.
Müller-Ladner, Ulf
Engelhart, Merete
Hachulla, Eric
Ionescu, Ruxandra Maria
Gheorghiu, Ana Maria
Sunderkötter, Cord
Ingegnoli, Francesca
Mouthon, Luc
Smith, Vanessa
Cantatore, Francesco Paolo
Ullman, Susanne
Pozzi, Maria Rosa
Wiland, Piotr
Alegre-Sancho, Juan Jose
Krummel-Lorenz, Brigitte
Herrmann, Kristine
De Langhe, Ellen
Anic, Branimir
Üprus, Maria
Yavuz, Sule
de Souza Müller, Carolina
Agachi, Svetlana
Zenone, Thierry
Stebbings, Simon
Vacca, Alessandra
Stamp, Lisa
Solanki, Kamal
Veale, Douglas
Loyo, Esthela
Tanaseanu, Cristina-Mihaela
Foti, Rosario
Ancuta, Codrina
Maurer, Britta
dela Peña Lefebvre, Paloma García
Sibilia, Jean
Litinsky, Ira
Del Galdo, Francesco
Seskute, Goda
Saketkoo, Lesley Ann
Kerzberg, Eduardo
Limonta, Massimiliano
Spertini, François
Martin, Thierry
Chung, Lorinda S
Schmeiser, Tim
Majewski, Dominik
Bernardino, Vera
Riemekasten, Gabriela
Rezus, Elena
Sarzi Puttini, Piercarlo
Kötter, Ina
Sfikakis, Petros
Furst, Daniel
Ramazan, Ana-Maria
de Vries-Bouwstra, Jeska
Dagna, Lorenzo
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 16 October 2024
First Online: 31 October 2024
Declarations
:
: This project is approved by ethical approval of the Cantonal Ethics Commission Zurich (KEK-ZH) for observational studies (BASEC-Nr 2018–02165) and by ethical approval for collection of data (BASEC KEK-Nr.-2016-01515). Besides, the project was approved by the EUSTAR Steering Committee (CP93).
: All authors gave their consent for the publishing of the article.
: None: AG, SJ; NG, PEC; JHD; MMC, ES, JH; VR, FO, ML,EJK, KE, FDG, MV; AMHV, AG;EZ: speaking and lecture fees, consulting/advisory: Janssen, GSK, Boehringer Ingelheim. MET has/had consultancy relationship with and/or has received research funding from and/or has served as a speaker for the following companies in the area of potential treatments for systemic sclerosis and its complications in the last three calendar years: Abbvie, Boehringer Ingelheim, Janssen, UCB, Lilly, Pfizer and Novartis.OD has/had consultancy relationship with and/or has received research funding from and/or has served as a speaker for the following companies in the area of potential treatments for systemic sclerosis and its complications in the last three calendar years: 4P-Pharma, Abbvie, Acceleron, Alcimed, Altavant, Amgen, AnaMar, Argenx, Arxx, AstraZeneca, Blade, Bayer, Boehringer Ingelheim, Corbus, CSL Behring, Galderma, Galapagos, Glenmark, Gossamer, Horizon, Janssen, Kymera, Lupin, Medscape, Merck, Miltenyi Biotec, Mitsubishi Tanabe, Novartis, Orion, Prometheus, Redxpharma, Roivant, Topadur and UCB. Patent issued “mir-29 for the treatment of systemic sclerosis” (US8247389, EP2331143). Co-founder of CITUS AG.
